All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Corneal procedures can be performed that reshape the anterior surface of the cornea, and therefore change the refraction of the cornea. While the initial procedure can cause an immediate change to the shape of the anterior surface of the cornea, the cornea, after some period of time following the procedure, may respond biologically to the procedure. The biological response can modify the shape relative to the immediate post-procedure shape. The final shape of the anterior surface of the cornea therefore depends on both the change induced by the procedure as well as the biological response of the cornea. When determining how to achieve a particular refraction correction for a patient, it is therefore not only important to understand the immediate effect the procedure will have on the anterior surface of the cornea, but also any biological response the cornea may have to the procedure.
One method of changing the curvature of the anterior surface of the lens is by implanting a corneal inlay within the cornea. Some inlays do not have intrinsic power because the index of refraction of the inlay material is the same, or substantially the same, as the cornea. Thus, there is no significant refraction of light at the inlay/cornea interface. For these inlays, the entire refractive effect on the eye is achieved due to the shape change to the anterior surface of the cornea. Reshaping the anterior corneal surface is very effective in altering the optical properties of the human eye because the index of refraction difference is large at the air/anterior corneal surface boundary, i.e., the difference is 1.376−1. Very strong “bending” of light occurs at the anterior corneal surface. However, the biological response of the cornea to the inlay must also be taken into account.
For some types of inlays it was originally thought that the profile of the change to the cornea was the same as the inlay profile. For example, it was thought that the anterior surface of the inlay would translate almost or substantially exactly and cause the cornea anterior surface to assume the same shape. For corneal inlays described in U.S. patent applications: 60/776,548, filed Feb. 24, 2006; Ser. No. 11/554,544, filed Oct. 30, 2006; 61/042,659, filed Apr. 4, 2008; 61/155,433, filed Feb. 25, 2009; Ser. No. 11/738,349, filed Apr. 20, 2007; and Ser. No. 12/418,325, filed Apr. 3, 2009, which are incorporated by reference herein, however, it has empirically been shown by the Applicants that the final anterior corneal shape is not, in fact, the same as the shape of the corneal inlay. For example, the cornea's biological response to an inlay's implantation was clinically observed in U.S. Pat. No. 8,057,541, filed Oct. 30, 2006 (the disclosure of which is incorporated herein by reference), where it was observed that the central anterior surface elevation change was less than the center thickness of the inlay. The cornea's biological response to the inlays was also discussed in U.S. Pub. No. 2008/0262610, filed Apr. 20, 2007, and in U.S. Pub. No. 2009/0198325, filed Apr. 3, 2009, the disclosures of which are incorporated by reference herein. Because the final shape of the anterior surface of the cornea will not simply be the same as the shape of the inlay, the question remains how to achieve the final anterior corneal surface shape.
One aspect of the disclosure is a method of performing a vision correction procedure, comprising calculating an 8th order polynomial base shape for a central region of the patient's anterior corneal surface, wherein the base shape provides for near and distance vision within the pupil; selecting a corneal inlay for implantation within the cornea that will change the shape of the anterior cornea surface to the 8th order polynomial.
In some embodiments the method further comprises scaling the 8th order polynomial base shape to provide a desired amount of near and distance visual acuity for the patient, and wherein the selecting step comprises selecting an inlay for implantation that will change the shape of the anterior corneal surface to the scaled 8th order polynomial. Scaling can comprise changing the central height of the 8th order polynomial base shape. Scaling can comprise changing the radial dimension of the 8th order polynomial base shape. Scaling the 8th order base shape can enhance near visual acuity and reduce distance visual acuity. Scaling the 8th order base shape can enhance distance visual acuity and reduce near visual acuity.
In some embodiments selecting the inlay for implantation comprises selecting an inlay with an anterior surface with a shape that is not an 8th order polynomial.
The disclosure herein provides a method of determining a desired shape for the anterior surface of the cornea. The response of the corneal tissue to the inlay's shape and volume is first determined, especially of the stroma and epithelium anterior to the inlay. This response is reduced to a functional relationship predicting the change to the anterior corneal surface for a given inlay design. By other techniques, such as optical design analysis or empirical analysis of clinical data, the desired optical effect is then determined, and the targeted anterior corneal surface required is then calculated. Using the functional biological relationship from the previous step, the required inlay design (shape and volume) is then calculated.
The disclosure herein discloses the nominal shape of an anterior corneal surface that can be produced by implanting a corneal inlay in the corneal stroma using a LASIK flap or otherwise, and that provides good distance, intermediate and near vision. Nominal shapes are provided for an exemplary 2.0 mm diameter inlay design.
The method of determining the surface shape of the anterior surface of the cornea herein includes using clinical measurement of the anterior corneal surface change after a 2.0 mm diameter inlay was implanted to show that the anterior corneal surface change can be fit to an 8th order symmetric polynomial. Using a surface description constrained to an 8th order symmetric polynomial, a range of shapes optimal for near and distance vision is then derived by theoretical ray trace methods. This aspect is described in detail in US Pub. No. 2009/0198325, incorporated herein by reference. The average of the anterior corneal surface shape change for subjects with the 2 mm diameter design establishes the ideal corneal shape because the clinical data demonstrates good distance, intermediate, and near visual acuity in the treated eye. This inlay design also provides a shape that is within the range of the theoretically ideal shapes from ray-trace analysis. The method also illustrates that there is a nominal basic biomechanical “shape,” from which each individual subject's anterior corneal surface shape can be calculated, by a scaling of the central height change and the diameter of the anterior corneal surface effect.
Background and Methods. The disclosure describes the determination of a desired anterior corneal shape. The anterior corneal shape for a given corneal inlay subject is derived from wavefront measurements recorded with the Tracey aberrometer. The wavefront is a measure of the optical properties of any optical system. If the only change to the human eye is the presence of the inlay, then by subtracting the postoperative wavefront from the preoperative wavefront, one derives the change due to only the inlay. The wavefront (WF) difference map provides a 3D profile of the anterior corneal surface change. The 3D height profile is calculated from the WF difference map by dividing by the cornea-air index of refraction difference (1.376−1).
To calculate the mean radial anterior corneal surface height change profile (“height profile”), for a given subject, we average the three dimensional (“3D”) height profile in 32 radial meridians, around the full 3D profile, centered on the peak of the 3D height profile.
The data presented in this analysis was derived from clinical studies.
Parameterization of the Anterior Corneal Surface Change. Because the inlay is circularly symmetric, the change to the anterior corneal surface is substantially symmetric. It is of note that while the term “symmetric” is used herein, it is understood that this term or derivatives of it include surfaces or changes that are not perfectly symmetric, but are substantially symmetric. For example, corneal flaps are not perfectly symmetrical since they have a hinge, and thus the final shape change may not be perfectly symmetrical. These shape changes are still considered symmetric as that term is used herein. The functional representation of the anterior corneal surface is thus generally an even function of the radius.
P(r)=[a0+a2(r)2+a4(r)4+a6(r)6+a8(r)8]
The first step in correcting the vision of a subject by altering the cornea is generally determining the desired post-operative shape of the anterior corneal surface which will provide the desired refractive power change (i.e., determining the shape change for the anterior surface of the cornea). The shape of the desired anterior surface may be the result of a biomechanical response as well as epithelial remodeling as a result of the vision correction procedure. Corneal epithelial remodeling will be described in more detail below. Based on a biomechanical response and an epithelial response, the vision correction procedure is performed (e.g., implanting an inlay) to induce the desired anterior surface change. This disclosure includes an exemplary method of determining a desired anterior corneal shape to provide for corrective vision. One particular embodiment in which the method includes implanting an inlay within the cornea to provide for a zone in the center of the cornea that provides near vision and a zone in the periphery that provides distance vision will be described. In some embodiments a central zone on the anterior corneal surface with a sharp transition is preferred (i.e., substantially without an outer effect zone). A sharp transition maximizes both the near and distance power efficiencies. In practice, the effects of epithelial remodeling typically prevent “sharp” transitions. Empirically, the anterior surface change induced by the inlay can be given by a symmetric polynomial of at least eighth order:
Elev(r)=a0+αa2×r2+a4×r4+a6×r6+a8×r8
Where “Elev” is the change in anterior corneal surface elevation due to the inlay,
The elevation change discussed herein is azimuthally symmetric in plane perpendicular to the axis of the cornea. In other embodiments, however, orthogonal asymmetries may be included with more complex inlay designs, attempting to correct for corneal astigmatism, pre-existing in the subject's eye. Physically, there are useful restrictions on the form of the elevation expression. At r=0, the elevation change is maximal and is central height “hctr”. From the symmetry, at r=0, the first derivative of elevation expression must be zero. The extent of the inlay-induced change is limited to a maximal radius (rz), where Elev(rz)=0. And because the elevation smoothly transitions to the original cornea at rz, the first derivative is normally also zero; i.e., dElev(rz)/dr=0.
With these restrictions, the elevation change can be characterized by four independent parameters: hctr, rz, a6 and a8. And the remaining coefficients are given by:
a0=hctr
a2=2*alpha/rz^2−beta/2/rz
a4=beta/2/rz^3−alpha/rz^4
Where:
alpha=−hctr−a6*rz^6−a8*rz^8
beta=−6*a6*rz^5-8*a8*rz^7
Thus, the ideal anterior corneal elevation change can be expressed by four independent parameters: hctr, rz, a6 and a8.
Table 1 provides ideal anterior corneal surface changes for three spectacle ADD powers (1.5 diopters, 2.0 diopters, and 2.5 diopters) and for three pupil sizes (small, nominal and large) when using near vision, derived theoretically by ray-trace analysis, which is described below.
Performing the optical ray-trace optimization to derive the optimal anterior corneal elevation change (Elev) requires a model eye which mimics the key optical functions of the human eye. The finite eye model by Navarro (Accommodation dependent model of the human eye with aspherics, R. Navarro. Et al, JOSA Vol 2 No 8 1985 p. 1273-1281) provides one such model. For these design purposes, the Navarro model provides anatomically correct values for the corneal physical and optical properties and provides total eye properties such as normal values for the total eye spherical aberrations, chromatic aberration and Stiles-Crawford effect. Other model eyes can be also used.
To include the anterior corneal elevation change (Elev) in the Navarro eye model, the Elev surface is added to the anterior surface of the Navarro eye model. Calculations of the image quality created by the anterior surface change to the eye model are accomplished using any of many commercial ray-trace software packages. For the examples provided, the Zemax-EE Optical Design Program (2008) from the Zemax Development Corporation was used.
The objective of the ray-trace optimization is to find the elevation surface parameters (hctr, rz, a6 and a8) that maximize the optical performance for a given set of assumptions. There are many optical metrics of image quality used in optical design. Of these, the Modulation Transfer Function (MTF) is particularly useful for optical designs, using any combination of optical surfaces of any shape. The MTF is the efficiency of transferring the contrast of the original object to the contrast of the image of the object on the human retina. The MTF efficiency (modulation) is plotted as a function of the spatial frequency information in the image of the object. The spatial frequency can be thought of as one divided by the size of features in the image. Thus, large spatial frequencies represent very fine features in the object, and low spatial frequencies represent very large features in the object. The image quality is maximized when the MTF values at targeted spatial frequencies have their highest values.
The assumptions are derived from the inlay's design requirement to provide a good distance image from light rays passing mainly through the peripheral region between the pupil diameter and the inlay's effect zone (rz), and a good near image for light rays passing through the central effect zone. Thus, the ray-trace program is set with at least two configurations. In the first, the object for the eye model is set to infinity (e.g., looking at a distant object). In the second configuration, the object is set at a near distance. The typical distance of near work and ophthalmic prescription is 40 cm, which corresponds to a spectacle power requirement of 2.5 diopters.
For each configuration, the model eye's pupil size must be set. Of the many choices, two are the most logical. In the first, the pupil size is set the same for both configurations and the goal of the optimization is to find the elevation parameters which give equal distance and near image quality. The second choice is to set separate pupil sizes for the distance and near configurations. The near configuration pupil size is set to subject's pupil size in a well illuminated setting i.e., the peripheral distance zone is effectively zero. This condition provides the maximal near distance capability. The distance configuration pupil size is set to the subject's night-time or dim-light pupil size, where distance vision is maximized. For the examples provided herein, the latter method was used, using different pupil sizes for the distance and near configurations. Note that regardless of the method chosen, the same range of ideal elevation profiles (e.g., Table 1) will be found.
The human pupil size varies for a given set of illumination conditions, with two important trends. As an individual ages, the nighttime pupil size decreases. Additionally, when looking at a near object, the pupil diameter reduces by about 0.5 mm. Based on literature and clinical experience, the near configuration pupil in bright lighting is considered “small” if approximately 2.5 mm in diameter, “nominal” if approximately 3.0 mm, and “large” if approximately 3.5 mm in diameter. For the distance configuration, the nighttime pupil sizes vary greatly, and any loss of distance vision is compensated for by the fellow eye. Thus, one nighttime pupil size is sufficient for design purposes and a diameter of 5.0 mm is suggested by the literature/clinical experience.
The optimization tools of the ray-trace software program are now utilized. The elevation parameters (hctr, rz, a6 and a8) are varied until the MTF of the near configuration is maximized while simultaneously maximizing the MTF of the distance configuration. The ideal design is clearly a function of the assumed pupil sizes. In practice, subject may be screened preoperatively, allowing the surgeon to select the inlay design most appropriate for the subject's pupil size range and desired visual outcome.
Clinically Derived Optimal Anterior Corneal Surface Profile. Though the theoretical analysis provides a range of theoretical ideal optical designs (Table 1), for the assumptions noted, the analysis does not guarantee that the precise predicted anterior corneal shapes are realizable. For example, some 8th order polynomial shapes with a certain degree of steepness are not realizable. Biomechanics limit the combinations of coefficients that can be obtained.
As shown in
The disclosure herein generally provides for methods of treating presbyopia by creating a central near vision zone while maintaining a peripheral distance vision zone (both within the pupil). There is a tradeoff between near and distance visual acuity. More near visual acuity generally results in less distance visual acuity, and likewise more distance visual acuity results in less near visual acuity. Depending on the patient and the specific type of vision correction, there may be instances where it is desirable to achieve more near vision acuity while sacrificing some distance vision. Similarly, in some instances it may be desirable to retain as much distance vision as possible, and thus limit the amount of reshaping that occurs to the anterior corneal surface. While the disclosure herein focuses on vision correction procedures that provide for both good near vision and good distance vision for a variety of different preferred refractive adds and pupil size combinations, it may be desirable to perform vision correction procedures that provide for either more near, and thus less distance, or more distance, and thus less near. Thus the disclosure herein describes methods of tailoring a vision correction to a particular patient, or to a group of patients, as opposed to using a single inlay for all vision correction procedures to treat presbyopia. By way of example, inlays with a diameter larger than 2.0 mm, such as between about 2.75 mm to about 3.25 mm (e.g., 2.8 mm, 2.9 mm, 3.0 mm, 3.1 mm, 3.2 mm), can be implanted in the cornea to provide more near visual acuity and less distance visual acuity than an inlay with a diameter of about 2.0 mm. The reason is that, generally, as the diameter of the inlay that is implanted increases in size, more of the anterior corneal surface changes shape, and thus more near visual acuity is provided while reducing the amount of distance visual acuity. Similarly, if more distance vision is desired, the inlay for implantation can be designed to be thinner in the central region. In general a thinner central height will act to reduce the shape change, thus reducing the near vision and maintaining more distance vision. The inlay can thus be selected based on the desired vision correction.
In some embodiments there could be a plurality of different inlays to be chosen from based on the individual needs of the patient. Alternatively, a patient-specific inlay could be designed and implanted.
For example, hctr values in the 2-5 micron range (i.e., less than the exemplary 5-10 micron range above) will, however, also provide vision correction. In these methods some near vision will still be provided to the patient, with less compromise to the distance vision than hctr values in the 5-10 micron range.
This 2 mm design response demonstrates good visual acuity.
Mean Biomechanical Corneal Response For Good Clinical Outcomes. Based on the observations above, it is apparent that a “base” anterior corneal height profile exists, representing the fundamental response of the cornea's stroma and epithelium to the inlay shape and volume. And the anterior height profile for each subject is a scaling in height and effect radius, from the base anterior corneal height profile. The individual subject response is a modification of the basic biomechanical response, due to more subtle changes between subjects. These changes include differences in the eye lid forces, differences in epithelial layer thicknesses, and possible differences in the structure of the stromal tissue, above the inlay.
A unique “base” profile exists with a set of coefficients (an), and individual subject profiles vary depending on two parameters: a scaling in the magnitude of the profile (δi) and a scaling in the radial direction (αi). The general form of the individual subject fit becomes:
Pi(r)=δi[a0+a2(αir)2+a4(αir)4+a6(αir)6+a8(air)8]
where each subject is “i”, and a0 to a8 are the coefficients of the basic shape. Each subject's anterior corneal shape is given by a specific combination of δi and αi. A statistical recursive fit analysis yielded the parameters for the base shape and the individual subject scaling parameters for the two inlay designs.
Table 2 lists the individual subject scaling parameters (δi and αi), and the base profile fit parameters (an) for the 2.0 mm diameter inlay design. The root mean square difference between the individual subject fit and the original clinical data, as a percentage of the base shape's central height (a0) is also provided. The majority of values are less than about 3%.
The base anterior height profile is shown in
In
While the disclosure herein describes the methods of determining and creating desired shapes by implanting an inlay within the cornea, other techniques can be used to create these shapes. For example, a LASIK procedure can be carried out to achieve the shapes herein. An example would be in the case of presby LASIK, a surgical technique for presbyopic visual correction using Excimer LASER ablation. Alternatively, the shapes can be achieved using INTRACOR, which uses a femtosecond laser to treat presbyopia. Other corneal reshaping methods include corneal thermoplasty (CT) and alteration of the corneal shape by cross-linking.
As set forth herein, it is useful to identify a nominal and/or range of anterior surface changes that provide good distance, intermediate and near vision for corneal inlay designs that are described as modifying the anterior corneal surface shape as described in U.S. patent applications: 60/776,548, filed Feb. 24, 2006; Ser. No. 11/554,544, filed Oct. 30, 2006; 61/042,659, filed Apr. 4, 2008; 61/155,433, filed Feb. 25, 2009; Ser. No. 11/738,349, filed Apr. 20, 2007; and Ser. No. 12/418,325, filed Apr. 3, 2009. If the design is to be changed, knowledge of the desired anterior corneal surface and the range of anterior surfaces allows prediction of acceptable new inlay designs. The methods herein of determining a desired shape of an anterior corneal surface can be used for other approaches, and are not limited to determining shapes due to the implantation of an inlay. For example, the methods can be used in determining shapes based on LASIK procedures. Additionally, the methods herein can be used for procedures that change the shape of the cornea following the removal of a lens-shaped portion of stromal tissue that may be cut by, for instance, a femtosecond laser. The shape of the lens can be modified to create a final corneal shape as described herein.
In
In some embodiments the inlay has a diameter between about 1 mm and about 3 mm, and in some particular embodiments the inlay is about 2 mm in diameter. In some embodiments the inlay central thickness (from anterior to posterior surfaces) is about 20 microns to about 40 microns, while in some particular embodiments the inlay central thickness is about 30 microns, and in some more particular embodiment the central thickness is about 32 microns. In some embodiments the inlay has an edge thickness of about 3 microns to about 16 microns, and in some particular embodiments the edge thickness is about 12 microns. In some embodiments the anterior surface radius of curvature is about 7 mm to about 13 mm, and in some particular embodiments the anterior surface radius of curvature is about 10 mm. In some embodiments the posterior surface radius of curvature is about 5 mm to about 12 mm, and in some particular embodiments the posterior surface radius of curvature is about 8.5 mm.
To increase the diopter power within the “effect” zone 43, the small inlay has a higher curvature than the pre-implant anterior corneal surface to increase the curvature of the anterior corneal surface within the “effect” zone 43. The inlay may further increase the diopter power within the “effect” zone 43 by having an index of refraction that is higher than the index of refraction of the cornea (ncornea=1.376). Thus, the increase in the diopter power within the “effect” zone 43 may be due to the change in the anterior corneal surface induced by the inlay or a combination of the change in the anterior cornea surface and the index of refraction of the inlay. For early presbyopes (e.g., about 45 to 55 years of age), at least 1 diopter is typically required for near vision. For complete presbyopes (e.g., about 60 years of age or older), between 2 and 3 diopters of additional power is required.
An advantage of the small intracorneal inlay is that when concentrating on nearby objects 45, the pupil naturally becomes smaller (e.g., near point miosis) making the inlay effect even more effective. Further increases in the inlay effect can be achieved by simply increasing the illumination of a nearby object (e.g., turning up a reading light).
Because the inlay is smaller than the diameter of the pupil 40, light rays 47 from distant objects 46 by-pass the inlay and refract using the region of the cornea peripheral to the “effect” zone to create an image of the distant objects on the retina 42, as shown in
This application claims priority to U.S. Prov. App. No. 61/799,847, filed Mar. 15, 2013, which is incorporated by reference herein. This application is also a continuation-in-part of U.S. application Ser. No. 12/877,799, filed Sep. 8, 2010, now abandoned, which is incorporated by reference herein. This application is also a continuation-in-part of pending U.S. application Ser. No. 12/418,325, filed Apr. 3, 2009, now U.S. Pat. No. 8,900,296. U.S. application Ser. No. 12/418,325 also claims priority to U.S. Prov. App. No. 61/042,659, filed Apr. 4, 2008 and U.S. Prov. App. No. 61/155,433, filed Feb. 25, 2009. All of the aforementioned applications are incorporated by reference herein. This application is related to and incorporates herein by reference the following U.S. patent applications: 60/776,548, filed Feb. 24, 2006; Ser. No. 11/554,544, filed Oct. 30, 2006; 61/042,659, filed Apr. 4, 2008; 61/155,433, filed Feb. 25, 2009; Ser. No. 11/738,349, filed Apr. 20, 2007; and Ser. No. 12/418,325, filed Apr. 3, 2009.
Number | Name | Date | Kind |
---|---|---|---|
2714721 | Stone, Jr. | Aug 1955 | A |
3091328 | Leonardos | May 1963 | A |
3168100 | Rich | Feb 1965 | A |
3343657 | Speshyock | Sep 1967 | A |
3379200 | Pennell | Apr 1968 | A |
3482906 | Volk | Dec 1969 | A |
3743337 | Crary | Jul 1973 | A |
3770113 | Thomas | Nov 1973 | A |
3879076 | Barnett | Apr 1975 | A |
3950315 | Cleaver | Apr 1976 | A |
3996627 | Deeg et al. | Dec 1976 | A |
4030480 | Meyer | Jun 1977 | A |
4037604 | Newkirk | Jul 1977 | A |
4037866 | Price | Jul 1977 | A |
4039827 | Zdrok et al. | Aug 1977 | A |
4065816 | Sawyer | Jan 1978 | A |
4071272 | Drdlik | Jan 1978 | A |
4093291 | Schurgin | Jun 1978 | A |
4136406 | Norris | Jan 1979 | A |
4157718 | Baehr | Jun 1979 | A |
4184491 | McGannon | Jan 1980 | A |
4194814 | Fischer et al. | Mar 1980 | A |
4238524 | LaLiberte et al. | Dec 1980 | A |
4257521 | Poler | Mar 1981 | A |
4268133 | Fischer et al. | May 1981 | A |
4326306 | Poler | Apr 1982 | A |
4357940 | Muller | Nov 1982 | A |
4392569 | Shoup | Jul 1983 | A |
4418991 | Breger | Dec 1983 | A |
4423809 | Mazzocco | Jan 1984 | A |
4428746 | Mendez | Jan 1984 | A |
4452235 | Reynolds | Jun 1984 | A |
4466705 | Michelson | Aug 1984 | A |
4490860 | Rainin | Jan 1985 | A |
4504982 | Burk | Mar 1985 | A |
4521210 | Wong | Jun 1985 | A |
4525044 | Bauman | Jun 1985 | A |
4545478 | Waldman | Oct 1985 | A |
4554115 | Neefe | Nov 1985 | A |
4554918 | White | Nov 1985 | A |
4565198 | Koeniger | Jan 1986 | A |
4573998 | Mazzocco | Mar 1986 | A |
4580882 | Nuchman et al. | Apr 1986 | A |
4586929 | Binder | May 1986 | A |
4604087 | Joseph | Aug 1986 | A |
4607617 | Choyce | Aug 1986 | A |
4616910 | Klein | Oct 1986 | A |
4618227 | Bayshore | Oct 1986 | A |
4619256 | Horn | Oct 1986 | A |
4624664 | Peluso et al. | Nov 1986 | A |
4624669 | Grendahl | Nov 1986 | A |
4640595 | Volk | Feb 1987 | A |
4646720 | Peyman et al. | Mar 1987 | A |
4655774 | Choyce | Apr 1987 | A |
4662370 | Hoffmann et al. | May 1987 | A |
4663358 | Hyon et al. | May 1987 | A |
4671276 | Reynolds | Jun 1987 | A |
4676792 | Praeger | Jun 1987 | A |
4697697 | Graham et al. | Oct 1987 | A |
4702244 | Mazzocco | Oct 1987 | A |
4709697 | Muller | Dec 1987 | A |
4721124 | Tuerkheimer et al. | Jan 1988 | A |
4726367 | Shoemaker | Feb 1988 | A |
4750901 | Molteno | Jun 1988 | A |
4762496 | Maloney et al. | Aug 1988 | A |
4766895 | Reynolds | Aug 1988 | A |
4769033 | Nordan | Sep 1988 | A |
4772283 | White | Sep 1988 | A |
4778462 | Grendahl | Oct 1988 | A |
4798609 | Grendahl | Jan 1989 | A |
4806382 | Goldberg et al. | Feb 1989 | A |
4836201 | Patton et al. | Jun 1989 | A |
4840175 | Peyman | Jun 1989 | A |
4842599 | Bronstein | Jun 1989 | A |
4844242 | Chen et al. | Jul 1989 | A |
4851003 | Lindstrom | Jul 1989 | A |
4860885 | Kaufman et al. | Aug 1989 | A |
4865552 | Maloney et al. | Sep 1989 | A |
4886488 | White | Dec 1989 | A |
4888016 | Langerman | Dec 1989 | A |
4897981 | Beck | Feb 1990 | A |
4911715 | Kelman | Mar 1990 | A |
4919130 | Stoy et al. | Apr 1990 | A |
4923467 | Thompson | May 1990 | A |
4934363 | Smith et al. | Jun 1990 | A |
4936825 | Ungerleider | Jun 1990 | A |
4946436 | Smith | Aug 1990 | A |
4955903 | Sulc et al. | Sep 1990 | A |
4968296 | Ritch et al. | Nov 1990 | A |
4971732 | Wichterle | Nov 1990 | A |
4976719 | Siepser | Dec 1990 | A |
5019084 | Aysta et al. | May 1991 | A |
5019098 | Mercier | May 1991 | A |
5022414 | Muller | Jun 1991 | A |
5030230 | White | Jul 1991 | A |
5041081 | Odrich | Aug 1991 | A |
5063942 | Kilmer et al. | Nov 1991 | A |
5071276 | Nielsen et al. | Dec 1991 | A |
5073163 | Lippman | Dec 1991 | A |
5092837 | Ritch et al. | Mar 1992 | A |
5098444 | Feaster | Mar 1992 | A |
5108428 | Capecchi et al. | Apr 1992 | A |
5112350 | Civerchia et al. | May 1992 | A |
5123905 | Kelman | Jun 1992 | A |
5123912 | Kaplan et al. | Jun 1992 | A |
5123921 | Werblin et al. | Jun 1992 | A |
5139518 | White | Aug 1992 | A |
5166712 | Portney | Nov 1992 | A |
5171213 | Price, Jr. | Dec 1992 | A |
5173723 | Volk | Dec 1992 | A |
5178604 | Baerveldt et al. | Jan 1993 | A |
5180362 | Worst et al. | Jan 1993 | A |
5181053 | Brown | Jan 1993 | A |
5188125 | Kilmer et al. | Feb 1993 | A |
5190552 | Kelman | Mar 1993 | A |
5192317 | Kalb | Mar 1993 | A |
5196026 | Barrett et al. | Mar 1993 | A |
5211660 | Grasso | May 1993 | A |
5225858 | Portney | Jul 1993 | A |
5229797 | Futhey et al. | Jul 1993 | A |
5244799 | Anderson | Sep 1993 | A |
5258042 | Mehta | Nov 1993 | A |
5270744 | Portney | Dec 1993 | A |
5273750 | Homiger et al. | Dec 1993 | A |
5282851 | Jacob-LaBarre | Feb 1994 | A |
5300020 | L'Esperance, Jr. | Apr 1994 | A |
5300116 | Chirila et al. | Apr 1994 | A |
5312413 | Eaton et al. | May 1994 | A |
5318044 | Kilmer et al. | Jun 1994 | A |
5318046 | Rozakis | Jun 1994 | A |
5318047 | Davenport et al. | Jun 1994 | A |
5336261 | Barrett et al. | Aug 1994 | A |
5338291 | Speckman et al. | Aug 1994 | A |
5344448 | Schneider et al. | Sep 1994 | A |
5346464 | Camras | Sep 1994 | A |
5370607 | Memmen | Dec 1994 | A |
5372577 | Ungerleider | Dec 1994 | A |
5385582 | Ommaya | Jan 1995 | A |
5391201 | Barrett et al. | Feb 1995 | A |
5397300 | Baerveldt et al. | Mar 1995 | A |
5405384 | Silvestrini | Apr 1995 | A |
5407241 | Harrison | Apr 1995 | A |
5428412 | Stoyan | Jun 1995 | A |
5433701 | Rubinstein | Jul 1995 | A |
5454796 | Krupin | Oct 1995 | A |
5458819 | Chirila et al. | Oct 1995 | A |
5467149 | Morrison et al. | Nov 1995 | A |
5474562 | Orchowski et al. | Dec 1995 | A |
5476445 | Baerveldt et al. | Dec 1995 | A |
5487377 | Smith et al. | Jan 1996 | A |
5489301 | Barber | Feb 1996 | A |
5493350 | Seidner | Feb 1996 | A |
5502518 | Lieberman | Mar 1996 | A |
5512220 | Roffman et al. | Apr 1996 | A |
5520631 | Nordquist et al. | May 1996 | A |
5521656 | Portney | May 1996 | A |
5530491 | Baude et al. | Jun 1996 | A |
5533997 | Ruiz | Jul 1996 | A |
5570142 | Lieberman | Oct 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5598234 | Blum et al. | Jan 1997 | A |
5616148 | Eagles et al. | Apr 1997 | A |
5620450 | Eagles et al. | Apr 1997 | A |
5628794 | Lindstrom | May 1997 | A |
5630810 | Machat | May 1997 | A |
5634943 | Villain et al. | Jun 1997 | A |
5643276 | Zaleski | Jul 1997 | A |
5647865 | Swinger | Jul 1997 | A |
5657108 | Portney | Aug 1997 | A |
5682223 | Menezes et al. | Oct 1997 | A |
5684560 | Roffman et al. | Nov 1997 | A |
5715031 | Roffman et al. | Feb 1998 | A |
5716633 | Civerchia | Feb 1998 | A |
5722948 | Gross | Mar 1998 | A |
5722971 | Peyman | Mar 1998 | A |
5728155 | Anello et al. | Mar 1998 | A |
5732990 | Yavitz et al. | Mar 1998 | A |
5752928 | de Roulhac et al. | May 1998 | A |
5755785 | Rowsey et al. | May 1998 | A |
5766181 | Chambers et al. | Jun 1998 | A |
5772667 | Blake | Jun 1998 | A |
5779711 | Kritzinger et al. | Jul 1998 | A |
5785674 | Mateen | Jul 1998 | A |
5800442 | Wolf et al. | Sep 1998 | A |
5800529 | Brauker et al. | Sep 1998 | A |
5805260 | Roffman et al. | Sep 1998 | A |
5810833 | Brady et al. | Sep 1998 | A |
5817115 | Nigam | Oct 1998 | A |
5824086 | Silvestrini | Oct 1998 | A |
5847802 | Menezes et al. | Dec 1998 | A |
5855604 | Lee | Jan 1999 | A |
5860984 | Chambers et al. | Jan 1999 | A |
5872613 | Blum et al. | Feb 1999 | A |
5873889 | Chin | Feb 1999 | A |
5876439 | Lee | Mar 1999 | A |
5888243 | Silverstrini | Mar 1999 | A |
5893719 | Radow | Apr 1999 | A |
5913898 | Feingold | Jun 1999 | A |
5919185 | Peyman | Jul 1999 | A |
5928245 | Wolf et al. | Jul 1999 | A |
5929968 | Cotie et al. | Jul 1999 | A |
5929969 | Roffman | Jul 1999 | A |
5935140 | Buratto | Aug 1999 | A |
5941583 | Raimondi | Aug 1999 | A |
5944752 | Silvestrini | Aug 1999 | A |
5945498 | Hopken et al. | Aug 1999 | A |
5964748 | Peyman | Oct 1999 | A |
5964776 | Peyman | Oct 1999 | A |
5968065 | Chin | Oct 1999 | A |
5976150 | Copeland | Nov 1999 | A |
5976168 | Chin | Nov 1999 | A |
5980549 | Chin | Nov 1999 | A |
6007510 | Nigam | Dec 1999 | A |
6010510 | Brown et al. | Jan 2000 | A |
6024448 | Wu et al. | Feb 2000 | A |
6033395 | Peyman | Mar 2000 | A |
6036714 | Chin | Mar 2000 | A |
6050999 | Paraschac et al. | Apr 2000 | A |
6055990 | Thompson | May 2000 | A |
6059775 | Nielsen | May 2000 | A |
6066170 | Lee | May 2000 | A |
6068642 | Johnson et al. | May 2000 | A |
6079826 | Appleton et al. | Jun 2000 | A |
6083231 | Van Noy et al. | Jul 2000 | A |
6086202 | Chateau et al. | Jul 2000 | A |
6090141 | Lindstrom | Jul 2000 | A |
6102946 | Nigam | Aug 2000 | A |
6110166 | Juhasz et al. | Aug 2000 | A |
6120148 | Fiala et al. | Sep 2000 | A |
6125294 | Scholl et al. | Sep 2000 | A |
6129733 | Brady et al. | Oct 2000 | A |
6139560 | Kremer | Oct 2000 | A |
6142969 | Nigam | Nov 2000 | A |
6143001 | Brown et al. | Nov 2000 | A |
6159241 | Lee et al. | Dec 2000 | A |
6171324 | Cote et al. | Jan 2001 | B1 |
6175754 | Scholl et al. | Jan 2001 | B1 |
RE37071 | Gabrielian et al. | Feb 2001 | E |
6183513 | Guenthner et al. | Feb 2001 | B1 |
6197019 | Peyman | Mar 2001 | B1 |
6197057 | Peyman et al. | Mar 2001 | B1 |
6197058 | Portney | Mar 2001 | B1 |
6203538 | Peyman | Mar 2001 | B1 |
6203549 | Waldock | Mar 2001 | B1 |
6203557 | Chin | Mar 2001 | B1 |
6206919 | Lee | Mar 2001 | B1 |
6210005 | Portney | Apr 2001 | B1 |
6214015 | Reich et al. | Apr 2001 | B1 |
6214044 | Silverstrini | Apr 2001 | B1 |
6217571 | Peyman | Apr 2001 | B1 |
6221067 | Peyman | Apr 2001 | B1 |
6228113 | Kaufman | May 2001 | B1 |
6228114 | Lee | May 2001 | B1 |
6248111 | Glick et al. | Jun 2001 | B1 |
6250757 | Roffman et al. | Jun 2001 | B1 |
6251114 | Farmer et al. | Jun 2001 | B1 |
6264648 | Peyman | Jul 2001 | B1 |
6264670 | Chin | Jul 2001 | B1 |
6264692 | Woffinden et al. | Jul 2001 | B1 |
6267768 | Deacon et al. | Jul 2001 | B1 |
6271281 | Liao et al. | Aug 2001 | B1 |
6277137 | Chin | Aug 2001 | B1 |
6280449 | Blake | Aug 2001 | B1 |
6280470 | Peyman | Aug 2001 | B1 |
6283595 | Breger | Sep 2001 | B1 |
6302877 | Ruiz | Oct 2001 | B1 |
6325509 | Hodur et al. | Dec 2001 | B1 |
6325792 | Swinger et al. | Dec 2001 | B1 |
6350272 | Kawesch | Feb 2002 | B1 |
6361560 | Nigam | Mar 2002 | B1 |
6364483 | Grossinger et al. | Apr 2002 | B1 |
6371960 | Heyman et al. | Apr 2002 | B2 |
6391230 | Sarbadhikari | May 2002 | B1 |
6398277 | McDonald | Jun 2002 | B1 |
6398789 | Capetan | Jun 2002 | B1 |
6428572 | Nagai | Aug 2002 | B2 |
6435681 | Portney | Aug 2002 | B2 |
6436092 | Peyman | Aug 2002 | B1 |
6447519 | Brady et al. | Sep 2002 | B1 |
6447520 | Ott et al. | Sep 2002 | B1 |
6458141 | Peyman | Oct 2002 | B1 |
6461384 | Hoffmann et al. | Oct 2002 | B1 |
6471708 | Green | Oct 2002 | B2 |
6474814 | Griffin | Nov 2002 | B1 |
6506200 | Chin | Jan 2003 | B1 |
6511178 | Roffman et al. | Jan 2003 | B1 |
6527389 | Portney | Mar 2003 | B2 |
6537283 | Van Noy | Mar 2003 | B2 |
6543610 | Nigam | Apr 2003 | B1 |
6544286 | Perez | Apr 2003 | B1 |
6551307 | Peyman | Apr 2003 | B2 |
6554424 | Miller et al. | Apr 2003 | B1 |
6554425 | Roffman et al. | Apr 2003 | B1 |
6557998 | Portney | May 2003 | B2 |
6581993 | Nigam | Jun 2003 | B2 |
6582076 | Roffman et al. | Jun 2003 | B1 |
6589057 | Keenan et al. | Jul 2003 | B1 |
6589203 | Mitrev | Jul 2003 | B1 |
6589280 | Koziol | Jul 2003 | B1 |
6592591 | Polla et al. | Jul 2003 | B2 |
6596000 | Chan et al. | Jul 2003 | B2 |
6605093 | Blake | Aug 2003 | B1 |
6607537 | Binder | Aug 2003 | B1 |
6607556 | Nigam | Aug 2003 | B1 |
6623522 | Nigam | Sep 2003 | B2 |
6626941 | Nigam | Sep 2003 | B2 |
6629979 | Feingold et al. | Oct 2003 | B1 |
6632244 | Nigam | Oct 2003 | B1 |
6641577 | Bille | Nov 2003 | B2 |
6645246 | Weinschenk, III et al. | Nov 2003 | B1 |
6648877 | Juhasz et al. | Nov 2003 | B1 |
6657029 | Vanderbilt | Dec 2003 | B2 |
6666887 | Callahan et al. | Dec 2003 | B1 |
6673112 | Nigam | Jan 2004 | B2 |
6702807 | Peyman | Mar 2004 | B2 |
6709103 | Roffman et al. | Mar 2004 | B1 |
6712848 | Wolf et al. | Mar 2004 | B1 |
6723104 | Ott | Apr 2004 | B2 |
6733507 | McNicholas et al. | May 2004 | B2 |
6733526 | Paul et al. | May 2004 | B2 |
6808262 | Chapoy et al. | Oct 2004 | B2 |
6824178 | Nigam | Nov 2004 | B2 |
6849090 | Nigam | Feb 2005 | B2 |
6855163 | Peyman | Feb 2005 | B2 |
6875232 | Nigam | Apr 2005 | B2 |
6879402 | Küchel | Apr 2005 | B2 |
6881197 | Nigam | Apr 2005 | B1 |
6893461 | Nigam | May 2005 | B2 |
6949093 | Peyman | Sep 2005 | B1 |
6955432 | Graham | Oct 2005 | B2 |
7128351 | Nigam | Oct 2006 | B2 |
7585075 | Marmo | Sep 2009 | B2 |
7699837 | Cox et al. | Apr 2010 | B2 |
7776086 | Miller | Aug 2010 | B2 |
7976577 | Silvestrini | Jul 2011 | B2 |
7992906 | Nigam | Aug 2011 | B2 |
8057541 | Dishier et al. | Nov 2011 | B2 |
8162953 | Dishier et al. | Apr 2012 | B2 |
8469948 | Dishier et al. | Jun 2013 | B2 |
8540727 | Dishier et al. | Sep 2013 | B2 |
8668735 | Nigam et al. | Mar 2014 | B2 |
8685292 | Mandler et al. | Apr 2014 | B2 |
20010027314 | Peyman | Oct 2001 | A1 |
20010031959 | Rozakis et al. | Oct 2001 | A1 |
20010051826 | Bogaert et al. | Dec 2001 | A1 |
20020010510 | Silvestrini | Jan 2002 | A1 |
20020055753 | Silvestrini | May 2002 | A1 |
20020063068 | Faxe | May 2002 | A1 |
20020101563 | Miyamura et al. | Aug 2002 | A1 |
20020103538 | Hughes et al. | Aug 2002 | A1 |
20020138069 | Peyman | Sep 2002 | A1 |
20020156467 | Tamayo | Oct 2002 | A1 |
20030014042 | Juhasz et al. | Jan 2003 | A1 |
20030033010 | Hicks et al. | Feb 2003 | A1 |
20030069637 | Lynch et al. | Apr 2003 | A1 |
20030078487 | Jeffries et al. | Apr 2003 | A1 |
20030208190 | Roberts et al. | Nov 2003 | A1 |
20030220653 | Perez | Nov 2003 | A1 |
20030229303 | Haffner et al. | Dec 2003 | A1 |
20040019379 | Glick et al. | Jan 2004 | A1 |
20040034413 | Christensen | Feb 2004 | A1 |
20040054408 | Glick et al. | Mar 2004 | A1 |
20040059320 | Telandro et al. | Mar 2004 | A1 |
20040073303 | Schanzlin | Apr 2004 | A1 |
20050080484 | Marmo et al. | Apr 2005 | A1 |
20050080485 | Nigam | Apr 2005 | A1 |
20050113844 | Nigam | May 2005 | A1 |
20050119738 | Nigam | Jun 2005 | A1 |
20050143717 | Peyman | Jun 2005 | A1 |
20050178394 | Slade | Aug 2005 | A1 |
20050182350 | Nigam | Aug 2005 | A1 |
20050182488 | Peyman | Aug 2005 | A1 |
20050203494 | Holliday | Sep 2005 | A1 |
20050222679 | Peyman | Oct 2005 | A1 |
20050246015 | Miller | Nov 2005 | A1 |
20050246016 | Miller et al. | Nov 2005 | A1 |
20050251115 | Cox et al. | Nov 2005 | A1 |
20050261752 | Chernyak | Nov 2005 | A1 |
20060020267 | Marmo | Jan 2006 | A1 |
20060105309 | Stoll et al. | May 2006 | A1 |
20060116762 | Hong et al. | Jun 2006 | A1 |
20060134170 | Griffith et al. | Jun 2006 | A1 |
20060142780 | Pynson et al. | Jun 2006 | A1 |
20060142781 | Pynson et al. | Jun 2006 | A1 |
20060173539 | Shiuey | Aug 2006 | A1 |
20060235430 | Le et al. | Oct 2006 | A1 |
20070027538 | Aharoni et al. | Feb 2007 | A1 |
20070106318 | McDonald | May 2007 | A1 |
20070106376 | Roberts et al. | May 2007 | A1 |
20070129797 | Lang et al. | Jun 2007 | A1 |
20070182920 | Back et al. | Aug 2007 | A1 |
20070203577 | Dishler et al. | Aug 2007 | A1 |
20070244559 | Shiuey | Oct 2007 | A1 |
20070255401 | Lang | Nov 2007 | A1 |
20070270945 | Kobayashi et al. | Nov 2007 | A1 |
20070280994 | Cunanan | Dec 2007 | A1 |
20080039825 | Lai et al. | Feb 2008 | A1 |
20080228177 | Moritz et al. | Sep 2008 | A1 |
20080262610 | Lang et al. | Oct 2008 | A1 |
20080269771 | Fulcher | Oct 2008 | A1 |
20080281304 | Campbell | Nov 2008 | A1 |
20090005764 | Knox et al. | Jan 2009 | A1 |
20090079940 | Dai et al. | Mar 2009 | A1 |
20090198325 | Holliday et al. | Aug 2009 | A1 |
20090216217 | Odrich et al. | Aug 2009 | A1 |
20090326650 | Zickler et al. | Dec 2009 | A1 |
20100069915 | Shiuey | Mar 2010 | A1 |
20100241060 | Roizman et al. | Sep 2010 | A1 |
20100331830 | Bischoff et al. | Dec 2010 | A1 |
20100331831 | Bischoff et al. | Dec 2010 | A1 |
20110029073 | Liang | Feb 2011 | A1 |
20110149241 | Dai | Jun 2011 | A1 |
20110208300 | de Juan et al. | Aug 2011 | A1 |
20110218623 | Dishler et al. | Sep 2011 | A1 |
20110256806 | Monnoyeur | Oct 2011 | A1 |
20110290681 | Nigam | Dec 2011 | A1 |
20120203238 | Nigam | Aug 2012 | A1 |
20120231416 | Drapeau et al. | Sep 2012 | A1 |
20120238806 | Mangiardi et al. | Sep 2012 | A1 |
20120245592 | Berner et al. | Sep 2012 | A1 |
20120245683 | Christie et al. | Sep 2012 | A1 |
20130023892 | Schneider et al. | Jan 2013 | A1 |
20130060255 | Feingold et al. | Mar 2013 | A1 |
20130211523 | Southard et al. | Aug 2013 | A1 |
20130231739 | Dishler et al. | Sep 2013 | A1 |
20130253527 | Schneider et al. | Sep 2013 | A1 |
20130253529 | Walter et al. | Sep 2013 | A1 |
20130281993 | Dishler et al. | Oct 2013 | A1 |
20130317605 | Ide et al. | Nov 2013 | A1 |
20130324983 | Liang | Dec 2013 | A1 |
20140128855 | Wottke et al. | May 2014 | A1 |
20140288540 | Bischoff et al. | Sep 2014 | A1 |
20160184085 | Schneider et al. | Jun 2016 | A1 |
20170319329 | Muller | Nov 2017 | A1 |
Number | Date | Country |
---|---|---|
3208729 | Sep 1983 | DE |
0308077 | Mar 1989 | EP |
0420549 | Apr 1991 | EP |
0729323 | Jul 1998 | EP |
0668061 | Sep 2000 | EP |
S5973622 | Apr 1984 | JP |
01-195853 | Aug 1989 | JP |
02-211119 | Aug 1990 | JP |
5502811 | May 1993 | JP |
H06510687 | Dec 1994 | JP |
08-501009 | Feb 1996 | JP |
9-504706 | May 1997 | JP |
2000506056 | May 2000 | JP |
2001091910 | Apr 2001 | JP |
2002537895 | Nov 2002 | JP |
03-508135 | Mar 2003 | JP |
2006181269 | Jul 2006 | JP |
2007500070 | Jan 2007 | JP |
2010507814 | Mar 2010 | JP |
2010220488 | Oct 2010 | JP |
2012523854 | Oct 2012 | JP |
2001-0013218 | Feb 2001 | KR |
2294722 | Mar 2007 | RU |
WO9208423 | May 1992 | WO |
WO9305731 | Apr 1993 | WO |
WO9626690 | Sep 1996 | WO |
WO9808549 | Mar 1998 | WO |
WO 9848715 | Nov 1998 | WO |
WO 9917691 | Apr 1999 | WO |
WO 9921513 | May 1999 | WO |
WO 9930645 | Jun 1999 | WO |
WO 0038594 | Jul 2000 | WO |
WO 03041616 | May 2003 | WO |
WO 03061518 | Jul 2003 | WO |
WO 03101341 | Dec 2003 | WO |
WO 2005020792 | Mar 2005 | WO |
WO2005082265 | Sep 2005 | WO |
WO 2005107648 | Nov 2005 | WO |
WO 2006029316 | Apr 2006 | WO |
WO 2006060363 | Jun 2006 | WO |
WO2006083708 | Aug 2006 | WO |
WO 2007101016 | Sep 2007 | WO |
WO 2007132332 | Nov 2007 | WO |
WO2010084595 | Jul 2010 | WO |
WO2011069907 | Jun 2011 | WO |
Entry |
---|
Spector, “Clinical Methods: The History, Physical, and Laboratory Examinations”, Butterworth Publishers, 3rd Edition, Chapter 58, The Pupils, (1990). |
Patel et al.; Refractive index of human corneal epithelium and stroma; J. Refract. Surg.; 11(2); Abstract; Mar. 1995 (pubmed Abstract only). |
Esguerra et al.; U.S. Appl. No. 14/463,355 entitled “Corneal implant storage, packaging, and delivery devices,” filed Aug. 19, 2014. |
Alio, J. J., et al., “Intracorneal Inlay Complicated by Intrastomal Epithelial Opacification,” Arch Ophthalmol, Oct. 2004; vol. 122; 6 pages. |
Cheng, et al.; “Predicting subjective judgment of best focus with objective image quality metrics”; Journal of Vision; Apr. 23, 2004; vol. 4(4); pp. 310-321. |
Churms, P.W., “The Theory and Computation of Optical Modifications to the Cornea in Refractive Keratoplasty,” American Journal of Optometry & Physiological Optics, 56:2, pp. 67-74, Feb. 1979. |
Huang et al.; Mathematical Model of Corneal Surface Smoothing After Laser Refractive Surgery; American Journal of Ophthalmology; Mar. 2003; pp. 267-278. |
Lang, A.J. et al., “First order design of intracorneal inlays: dependence on keratometric flap and corneal properties,” ARVO Abstracts 2006, poster No. 3591, May 3, 2006. |
Liou, H. L. et al., “Anatomically accurate, finite model eye for optical modeling”, Journal of the Optical Society of America, vol. 14, No. 8, Aug. 1997. |
Marsack,et al.; “Metrics of optical quality derived from wave aberrations predict visual performance”; Journal of Vision; Apr. 23, 2004; vol. 4(4); pp. 322-328. |
Navarro et al.; Accommodation-dependent model of the human eye with aspherics; J. Opt. Soc Am. A; vol. 2; No. 8; Aug. 1985; pp. 1273-1281. |
Petroll et al.; Confocal assessment of the cornal response to intracorneal lens insertion and laser in situ keratomileusis with flap creation using IntraLase; J Cataract Refract Surg; vol. 32; pp. 1119-1128; Jul. 2006. |
Reinstein et al.; Change in epithelial thickness profile 24 hours and longitudinally for 1 year after myopic LASIK: three-dimensional display with Artemis very high-frequency digital ultrasound; J Refract Surg. Mar. 2012; 28(3):195-201. |
Reinstein et al.; Epithelial thickness up to 26 years after radial keratotomy: three-dimensional display with Artemis very high-frequency digital ultrasound; J Refract Surg. Aug. 2011; 27(8):618-624. |
Reinstein et al.; Epithelial, stromal, and total corneal thickness in keratoconus: three-dimensional display with artemis very-high frequency digital ultrasound; J Refract Surg. Apr. 2010; 26(4):259-71. |
Reinstein et al.; Epithelial thickness after hyperopic LASIK: three-dimensional display with Artemis very high-frequency digital ultrasound; J Refract Surg. Aug. 2010;26(8):555-64. |
Reinstein et al.; Corneal epithelial thickness profile in the diagnosis of keratoconus; J Refract Surg. Jul. 2009; 25(7):604-10. |
Reinstein et al.; Stability of LASIK in topographically suspect keratoconus confirmed non-keratoconic by Artemis VHF digital ultrasound epithelial thickness mapping: 1-year follow-up; J Refract Surg. Jul. 2009; 25(7):569-77. |
Reinstein et al.; Epithelial, stromal, and corneal pachymetry changes during orthokeratology; Optom Vis Sci. Aug. 2009; 86(8):E1006-14. |
Reinstein et al.; Epithelial thickness profile changes induced by myopic LASIK as measured by Artemis very high-frequency digital ultrasound; J Refract Surg. May 2009; 25(5):444-50 (Author manusript). |
Reinstein et al.; Epithelial thickness in the normal cornea: three-dimensional display with Artemis very high-frequency digital ultrasound; J Refract Surg. Jun. 2008; 24(6):571-81 (Author manusript). |
Reinstein et al.; Epithelial and stromal changes induced by intacs examined by three-dimensional very high-frequency digital ultrasound; J Refract Surg. May-Jun. 2001; 17(3):310-8. |
Reinstein et al.; Epithelial and corneal thickness measurements by high-frequency ultrasound digital signal processing; Ophthalmology. Jan. 1994; 101(1):140-6. |
Reinstein et al.; High-frequency ultrasound measurement of the thickness of the corneal epithelium; Refract Corneal Surg. Sep.-Oct. 1993;9(5):385-7. |
Serrao et al.; Corneal epithelial healing after photorefractive keratectomy: analytical study; J. Cataract Refract Surg; vol. 31; pp. 930-937; May 2005. |
Thoft et al.; The X, Y, Z Hypothesis of Corneal Epithelial Maintenance; Investigative Ophthalmology & Visual Science; vol. 24; pp. 1442-1443; Oct. 1983. |
Watsky, M.A. et al., “Predicting Refractive Alterations with Hydrogel Keratophakia,” Investigative Opthalmology & Visual Science, vol. 26, pp. 240-243, Feb. 1985. |
Nigam et al.; U.S. Appl. No. 14/160,438 entitled “Coreal Implant Applicators,” filed Jan. 21, 2014. |
Sharma et al.; U.S. Appl. No. 14/211,714 entitled “Pre-treatment haze reduction for corneal inlays,” filed Mar. 14, 2014. |
Plambeck et al.; U.S. Appl. No. 14/352,628 entitled “Corneal implant storage and delivery devices,” filed Apr. 17, 2014. |
Holliday et al.; U.S. Appl. No. 14/547,931 entitled “Corneal inlay design and methods of correcting vision,” filed Nov. 19, 2014. |
Collins et al.; U.S. Appl. No. 14/575,833 entitled “Integrated part fixturing for lathing processes,” filed Dec. 18, 2014. |
Sharma; U.S. Appl. No. 14/427,510 entitled “Corneal implant edges and methods of use,” filed Mar. 11, 2015. |
Holliday et al.; U.S. Appl. No. 14/656,621 entitled “Methods of correcting vision,” filed Mar. 12, 2015. |
Esguerra et al.; U.S. Appl. No. 14/688,226 entitled “Corneal implant delivery devices and methods of use,” filed Apr. 16, 2015. |
Dymax; UV curable optical assembly; 2 pages; retrieved Mar. 4, 2015 from the internet (http:www.dymax.com/index.php/adhesives/optical). |
Jankov et al.; Laser intrastromal keratoplasty—case report; J. Refract.Surg.; 20(1); pp. 79-84; Jan.-Feb. 2004. |
Winn et al.; Factors affecting light-adapted pupil size in normal human subjects; Investigative Ophthalmology and Visual Science; 35(3); pp. 1132-1137; Mar. 1994. |
Walker et al.; Clinical Methods: The history, physical, and laboratory examinations; 3rd Edition; Chapter 58; Butterworth Publishers; Jul. 1990; 8 pages; retrieved from the internet (http://www.ncbi.nlm.nih.gov/books/NBK381). |
Plambeck et al.; U.S. Appl. No. 15/163,610 entitled “Corneal implant storage and delivery devices,” filed May 24, 2016. |
Dishler et al.; U.S. Appl. No. 15/219,130 entitled “Small diameter corneal inlays,” filed Jul. 25, 2016. |
Holliday; U.S. Appl. No. 15/313,297 entitled “Corneal implants and methods of manufacturing,” filed Nov. 22, 2016. |
Holliday et al.; U.S. Appl. No. 15/403,078 entitled “Methods of correcting vision,” filed Jan. 10, 2017. |
Schneider et al.; U.S. Appl. No. 15/413,269 entitled “Corneal implant inserters and methods of use,” filed Jan. 23, 2017. |
Le et al.; U.S. Appl. No. 15/508,499 entitled “Training cornea for refractive surgery training,” filed Mar. 3, 2017. |
Daxer et al.; Collagen fibrils in the human corneal stroma: Structure and aging; Ivest Opthalmol & Vis Sci.; 39(3); pp. 644-648; Mar. 1998. |
Number | Date | Country | |
---|---|---|---|
20140200665 A1 | Jul 2014 | US |
Number | Date | Country | |
---|---|---|---|
61799847 | Mar 2013 | US | |
61155433 | Feb 2009 | US | |
61042659 | Apr 2008 | US | |
60776458 | Feb 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12877799 | Sep 2010 | US |
Child | 14217056 | US | |
Parent | 12418325 | Apr 2009 | US |
Child | 12877799 | US | |
Parent | 11738349 | Apr 2007 | US |
Child | 12418325 | US | |
Parent | 11554544 | Oct 2006 | US |
Child | 11554544 | Oct 2006 | US |